Ventricular assist device, which is also known as VAD, is a mechanically assisted pump which is being used to support heart function and flow of blood in people who have weakened hearts. Ventricular assist device works by taking blood from a lower chamber of the heart and helps pump it to the body & organs similar to a healthy heart. A VAD supports patient’s heart through or after surgery until the heart recovers, while patient is waiting for a heart transplant or if patient is not eligible for a heart transplant. A VAD can also be a long-term solution for patients with cardiac disorders.

The global Ventricular Assist Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ventricular Assist Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ventricular Assist Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ventricular Assist Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ventricular Assist Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abiomed
Boston Scientific Corporation
Biotronik SE & Co. KG
LivaNova PLC
Medtronic plc
Berlin Heart
ReliantHeart
HeartWare International
Jarvik Heart
St. Jude Medical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Right Ventricular Assist Devices (RVAD)
Left Ventricular Assist Devices (LVAD)
Bipolar Ventricular Assist Devices (BVAD)

Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiology Centers